GlassScriptPhysician profile
Edward Capoccia
NPI 1891177051
$3,491.21
in general payments reported to CMS, 2019-2025
39 companies · $987 in 2025
The $987 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $424 · 2020: $219 · 2021: $205 · 2022: $761 · 2023: $230 · 2024: $667 · 2025: $987.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,883.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,883.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $924.93 | 2019-2025 | Ams 700, Rezum Generator, Advance Xp |
| Sumitomo Pharma America, INC. | $280.25 | 2023-2025 | Orgovyx, Gemtesa |
| Abbvie INC. | $275.37 | 2022-2025 | |
| Progenics Pharmaceuticals, INC. | $194.24 | 2021-2025 | |
| Verity Pharmaceuticals INC. | $167.34 | 2023-2025 | Trelstar, Tlando |
| Urogen Pharma, INC. | $142.92 | 2024-2025 | |
| Coloplast Corp | $116.68 | 2021-2025 | |
| Janssen Biotech, INC. | $112.86 | 2023-2025 | Erleada |
| Merck Sharp & Dohme LLC | $107.72 | 2022-2024 | Keytruda, Welireg, Lynparza |
| Photocure INC | $106.94 | 2024 | Cysview |
| Karl Storz Endoscopy-America | $101.97 | 2025 | N.A. |
| Astellas Pharma US INC | $96.38 | 2021-2025 | Padcev |
| Myovant Sciences INC. | $96.37 | 2021-2022 | |
| Urovant Sciences INC | $95.51 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $91.34 | 2022-2023 | Prolaris |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $74.62 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $51.62 | 2022 | |
| Tolmar, INC. | $47.80 | 2024 | |
| Novartis Pharmaceuticals Corporation | $36.08 | 2025 | |
| Cardinal Health 414 LLC | $31.23 | 2023 | |
| Kerecis Limited | $31.13 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Hollister Incorporated | $30.66 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $26.98 | 2024 | Lynparza |
| C. R. Bard, INC. & Subsidiaries | $24.35 | 2025 | Bard Urinary Drainage Bag |
| Laborie Medical Technologies Corp. | $21.78 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Dentsply Ih INC. | $20.19 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $20.17 | 2025 | |
| Antares Pharma, INC. | $17.92 | 2025 | Xyosted |
| Profound Medical Corp. | $16.01 | 2025 | Tulsa-Pro |
| Mimedx Group, INC. | $15.27 | 2025 | |
| Axogen | $14.69 | 2025 | |
| Tolmar Pharmaceuticals, INC. | $14.27 | 2022 | |
| Lumenis, INC | $14.17 | 2021 | |
| Halozyme INC | $14.14 | 2023 | |
| Ethicon US, LLC | $14.01 | 2025 | Vistaseal, Stratafix |
| Avation Medical, INC. | $13.90 | 2025 | Vivally System |
| Dendreon Pharmaceuticals LLC | $12.76 | 2022 | |
| Mission Pharmacal Company | $12.31 | 2022 | |
| Valencia Technologies Corporation | $4.33 | 2025 | Ecoin Device Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Capoccia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.